Disulfiram
Disulfiram, an approved medication for the treatment of alcohol
dependence, has been reported to inhibit MERS and SARS papain-like
protease in cell cultures but there is no clinical evidence of it.
However, it is debatable, whether HIV protease inhibitors could
effectively inhibit the 3-chymotrypsin-like, as well as, papain-like
proteases of 2019-nCoV, although, Disulfiram could possibly be screened
against 2019-nCoV by facilities that have sufficient capabilities of
bio-containment [37][47].9-nCoV / SARS-CoV-2 outbreak.